Actively Recruiting

Age: 2Years +
All Genders
NCT06883240

An Observational Study of Participants With Type 3 Von Willebrand Disease on Prophylactic Standard-of-Care Treatment

Led by Hoffmann-La Roche · Updated on 2026-04-17

40

Participants Needed

27

Research Sites

78 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This non-interventional study (NIS) is designed to collect information on the effectiveness and safety of treatment received in routine clinical care, as well as measure the health-related quality of life (HRQoL) of participants with Type 3 von Willebrand disease (VWD) receiving prophylactic therapy per local standard of care (SOC) over an observation period of at least 24 weeks.

CONDITIONS

Official Title

An Observational Study of Participants With Type 3 Von Willebrand Disease on Prophylactic Standard-of-Care Treatment

Who Can Participate

Age: 2Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Confirmed diagnosis of Type 3 von Willebrand disease (VWD) based on medical records
  • Adequate blood, liver, and kidney function
  • Previously used standard prophylactic therapy for VWD 1 to 3 times weekly and plans to continue the same regimen
  • For those able to have children: agreement to remain abstinent or use contraception as required
Not Eligible

You will not qualify if you...

  • Having inherited or acquired bleeding disorders other than Type 3 VWD
  • History of gastrointestinal bleeding within 18 months before enrollment or diagnosis of angiodysplasia
  • History of intracranial hemorrhage
  • Past or current treatment for blood clots or signs of clotting disease
  • Other conditions that raise bleeding or clotting risks, such as some autoimmune diseases
  • History of serious allergic reactions to monoclonal antibody treatments or emicizumab components
  • Use or planned use of systemic immune-modulating drugs (except anti-retroviral therapy) at enrollment

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 27 locations

1

UC Davis

Sacramento, California, United States, 95817

Actively Recruiting

2

University of Florida

Gainesville, Florida, United States, 32610

Actively Recruiting

3

University of Minnesota Medical Center

Minneapolis, Minnesota, United States, 55455

Actively Recruiting

4

Washington University School of Medicine

St Louis, Missouri, United States, 63110

Actively Recruiting

5

UZ Leuven Gasthuisberg

Leuven, Belgium, 3000

Actively Recruiting

6

The Hospital for Sick Children

Toronto, Ontario, Canada, M5G 1X8

Completed

7

McGill University Health Center

Montreal, Quebec, Canada, H4A 3J1

Actively Recruiting

8

IPS SURA Industriales Medellín

Medellín, Colombia

Actively Recruiting

9

Hopital Claude Huriez - CHU Lille

Lille, France, 59037

Actively Recruiting

10

Groupe Hospitalier Necker Enfants Malades

Paris, France, 75015

Actively Recruiting

11

Universitätsklinikum Bonn

Bonn, Germany, 53127

Actively Recruiting

12

Gerinnungszentrum Rhein-Ruhr;Gerinnungsambulanz

Duisburg, Germany, 47051

Actively Recruiting

13

Hämophiliezentrum Med. Klinik III/Institut für Transfusionsmedizin

Frankfurt/M., Germany, 60590

Actively Recruiting

14

Universita' Degli Studi La Sapienza-Ist.Di Ematologia

Rome, Lazio, Italy, 00161

Actively Recruiting

15

IRCCS Ca' Granda Ospedale Maggiore Policlinico

Milan, Lombardy, Italy, 20122

Actively Recruiting

16

AOU Careggi

Florence, Tuscany, Italy, 50134

Actively Recruiting

17

Kurume University Hospital

Fukuoka, Japan, 830-0011

Completed

18

Tokyo Medical University Hospital

Tokyo, Japan, 160-0023

Actively Recruiting

19

Erasmus MC

Rotterdam, Netherlands, 3015 GD

Actively Recruiting

20

Instytut Hematologii i Transfuzjologii

Warsaw, Poland, 02-776

Actively Recruiting

21

Charlotte Maxeke Johannesburg Academic Hospital

Johannesburg, South Africa, 2193

Actively Recruiting

22

Hospital Universitario la Paz

Madrid, Spain, 28046

Actively Recruiting

23

Hospital Universtiario Virgen del Rocio

Seville, Spain, 41013

Actively Recruiting

24

Sahlgrenska Universitetssjukhuset

Gothenburg, Sweden, S-413 45

Actively Recruiting

25

St Thomas' Hospital

London, United Kingdom, SE1 7EH

Actively Recruiting

26

Great Ormond Street Hospital

London, United Kingdom, WC1N 3JH

Actively Recruiting

27

Manchester Royal Infirmary

Manchester, United Kingdom, M13 9WL

Actively Recruiting

Loading map...

Research Team

R

Reference Study ID Number: WP45335 https://forpatients.roche.com/

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here